Literature DB >> 1289056

The expression of tissue and urokinase-type plasminogen activators in neural development suggests different modes of proteolytic involvement in neuronal growth.

Y Sumi1, M A Dent, D E Owen, P J Seeley, R J Morris.   

Abstract

Tissue and urokinase-type plasminogen activators are serine proteases with highly restricted specificity, their best characterised role being to release the broad specificity protease plasmin from inactive plasminogen. It has frequently been suggested that these, and similar proteases, are involved in axonal growth and tissue remodelling associated with neural development. To help define what this role might be, we have studied the expression of the plasminogen activators in developing rat nervous tissue. Urokinase-type plasminogen activator mRNA is strongly expressed by many classes of neurons in peripheral and central nervous system. We have analysed its appearance in spinal cord and sensory ganglia, and found the mRNA is detectable by in situ hybridisation very early in neuronal development (by embryonic day 12.5), at a stage compatible with it playing a role in axonal or dendritic growth. Tissue plasminogen activator mRNA, on the other hand, is expressed only by cells of the floor plate in the developing nervous system, from embryonic day 10.5 and thereafter. Immunohistochemical and enzymatic analysis showed that active tissue plasminogen activator is produced by, and retained within, the floor plate. A mechanism is suggested by which high levels of tissue plasminogen activator produced by the stationary cells of the floor plate could influence the direction of growth of commissural axons as they pass through this midline structure.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1289056     DOI: 10.1242/dev.116.3.625

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  28 in total

1.  The chemorepulsive activity of secreted semaphorins is regulated by furin-dependent proteolytic processing.

Authors:  R H Adams; M Lohrum; A Klostermann; H Betz; A W Püschel
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

2.  Nervous system-specific expression of a novel serine protease: regulation in the adult rat spinal cord by excitotoxic injury.

Authors:  I A Scarisbrick; M D Towner; P J Isackson
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

Review 3.  Navigation rules for vessels and neurons: cooperative signaling between VEGF and neural guidance cues.

Authors:  Sophie Chauvet; Katja Burk; Fanny Mann
Journal:  Cell Mol Life Sci       Date:  2013-03-12       Impact factor: 9.261

4.  Laminin degradation by plasmin regulates long-term potentiation.

Authors:  Y Nakagami; K Abe; N Nishiyama; N Matsuki
Journal:  J Neurosci       Date:  2000-03-01       Impact factor: 6.167

5.  Single-nucleotide polymorphism of the urokinase-plasminogen activator gene during aging and transformation of human diploid kidney cell cultures.

Authors:  Safedin H Beqaj; David Post; Jon M Ryan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Sep-Oct       Impact factor: 2.416

6.  Urokinase-type plasminogen activator (uPA) promotes ezrin-mediated reorganization of the synaptic cytoskeleton in the ischemic brain.

Authors:  Paola Merino; Ariel Diaz; Luis Guillermo Manrique; Lihong Cheng; Manuel Yepes
Journal:  J Biol Chem       Date:  2018-05-02       Impact factor: 5.157

7.  Real-time imaging of the axonal transport of granules containing a tissue plasminogen activator/green fluorescent protein hybrid.

Authors:  J E Lochner; M Kingma; S Kuhn; C D Meliza; B Cutler; B A Scalettar
Journal:  Mol Biol Cell       Date:  1998-09       Impact factor: 4.138

8.  Cross-talk of anosmin-1, the protein implicated in X-linked Kallmann's syndrome, with heparan sulphate and urokinase-type plasminogen activator.

Authors:  Youli Hu; David González-Martínez; Soo-Hyun Kim; Pierre Marc Gilles Bouloux
Journal:  Biochem J       Date:  2004-12-15       Impact factor: 3.857

Review 9.  Effect of feeding regimens on circadian rhythms: implications for aging and longevity.

Authors:  Oren Froy; Ruth Miskin
Journal:  Aging (Albany NY)       Date:  2010-12-11       Impact factor: 5.682

10.  Sites of urokinase-type plasminogen activator expression and distribution of its receptor in the normal human kidney.

Authors:  S N Wagner; M J Atkinson; C Wagner; H Höfler; M Schmitt; O Wilhelm
Journal:  Histochem Cell Biol       Date:  1996-01       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.